fosinopril and its Impurities
An angiotensin converting enzyme (ACE) inhibitor, Fosinopril is used for the treatment of hypertension and heart failure. It is a prodrug and is converted in vivo to the active form fosinoprilat. Reference standards of Fosinopril API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.


Fosinopril Related Compound E ((4S)-4-phenyl-1-[(R)-[(S)-1-hydroxy-2-methyl-propoxy](4-phenylbutyl) (1283459)
Fosinopril Related Compound E ((4S)-4-phenyl-1-[(R)-[(S)-1-hydroxy-2-methyl-propoxy](4-phenylbutyl) (1283459)
Catalogue No.:PA USP1283459
CAS :
NA
Molecular Formula : NA
Molecular Weight : NA


Fosinopril Related Compound F ((4S)-4-cyclohexyl-1-[(R)-[(S)-1-hydroxypropoxy](4-phenylbutyl)phosph (1283460)
Fosinopril Related Compound F ((4S)-4-cyclohexyl-1-[(R)-[(S)-1-hydroxypropoxy](4-phenylbutyl)phosph (1283460)
Catalogue No.:PA USP1283460
CAS :
NA
Molecular Formula : NA
Molecular Weight : NA


Sodium (2S,4S)-1-(2-((R)-((S)-2-methyl-1-(propionyloxy)propoxy)(4-phenylbutyl)phosphoryl)acetyl)-4-phenylpyrrolidine-2-carboxylate
Sodium (2S,4S)-1-(2-((R)-((S)-2-methyl-1-(propionyloxy)propoxy)(4-phenylbutyl)phosphoryl)acetyl)-4-phenylpyrrolidine-2-carboxylate
Catalogue No.:PA 06 0461002
CAS :
NA
Molecular Formula : C30H39NNaO7P
Molecular Weight : 579.61


Sodium (2S,4S)-4-cyclohexyl-1-(2-((R)-(4-phenylbutyl)((S)-1-(propionyloxy)propoxy)phosphoryl)acetyl)pyrrolidine-2-carboxylate
Sodium (2S,4S)-4-cyclohexyl-1-(2-((R)-(4-phenylbutyl)((S)-1-(propionyloxy)propoxy)phosphoryl)acetyl)pyrrolidine-2-carboxylate
Catalogue No.:PA 06 0461001
CAS :
NA
Molecular Formula : C29H43NNaO7P
Molecular Weight : 571.63